![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neutrophil diversity and plasticity in tumour progression and therapy
Sébastien Jaillon, Andrea Ponzetta, Diletta Di Mitri, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 485-503
Closed Access | Times Cited: 820
Sébastien Jaillon, Andrea Ponzetta, Diletta Di Mitri, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 485-503
Closed Access | Times Cited: 820
Showing 1-25 of 820 citing articles:
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1233
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1233
Macrophages as tools and targets in cancer therapy
Alberto Mantovani, Paola Allavena, Federica Marchesi, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 799-820
Open Access | Times Cited: 993
Alberto Mantovani, Paola Allavena, Federica Marchesi, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 799-820
Open Access | Times Cited: 993
Systemic immunity in cancer
Kamir J. Hiam-Galvez, Breanna M. Allen, Matthew H. Spitzer
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 345-359
Open Access | Times Cited: 922
Kamir J. Hiam-Galvez, Breanna M. Allen, Matthew H. Spitzer
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 345-359
Open Access | Times Cited: 922
The inflammatory pathogenesis of colorectal cancer
Mark R. Schmitt, Florian R. Greten
Nature reviews. Immunology (2021) Vol. 21, Iss. 10, pp. 653-667
Closed Access | Times Cited: 441
Mark R. Schmitt, Florian R. Greten
Nature reviews. Immunology (2021) Vol. 21, Iss. 10, pp. 653-667
Closed Access | Times Cited: 441
Neutrophils in cancer: heterogeneous and multifaceted
Catherine C. Hedrick, Ilaria Malanchi
Nature reviews. Immunology (2021) Vol. 22, Iss. 3, pp. 173-187
Closed Access | Times Cited: 429
Catherine C. Hedrick, Ilaria Malanchi
Nature reviews. Immunology (2021) Vol. 22, Iss. 3, pp. 173-187
Closed Access | Times Cited: 429
Liver tumour immune microenvironment subtypes and neutrophil heterogeneity
Ruidong Xue, Qiming Zhang, Qi Cao, et al.
Nature (2022) Vol. 612, Iss. 7938, pp. 141-147
Closed Access | Times Cited: 404
Ruidong Xue, Qiming Zhang, Qi Cao, et al.
Nature (2022) Vol. 612, Iss. 7938, pp. 141-147
Closed Access | Times Cited: 404
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome
Wolf H. Fridman, Maxime Meylan, Florent Petitprez, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 7, pp. 441-457
Closed Access | Times Cited: 361
Wolf H. Fridman, Maxime Meylan, Florent Petitprez, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 7, pp. 441-457
Closed Access | Times Cited: 361
Neutrophils in cancer carcinogenesis and metastasis
Shu-Min Xiong, Liaoliao Dong, Lin Cheng
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 313
Shu-Min Xiong, Liaoliao Dong, Lin Cheng
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 313
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Yan Tie, Fan Tang, Yuquan Wei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 271
Yan Tie, Fan Tang, Yuquan Wei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 271
Neutrophils in COVID-19
Nico Reusch, Elena De Domenico, Lorenzo Bonaguro, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 248
Nico Reusch, Elena De Domenico, Lorenzo Bonaguro, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 248
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Jiajie Hou, Michael Karin, Beicheng Sun
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 261-279
Open Access | Times Cited: 242
Jiajie Hou, Michael Karin, Beicheng Sun
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 261-279
Open Access | Times Cited: 242
Meta-hallmarks of aging and cancer
Carlos López‐Otín, Federico Pietrocola, David Roiz‐Valle, et al.
Cell Metabolism (2023) Vol. 35, Iss. 1, pp. 12-35
Open Access | Times Cited: 231
Carlos López‐Otín, Federico Pietrocola, David Roiz‐Valle, et al.
Cell Metabolism (2023) Vol. 35, Iss. 1, pp. 12-35
Open Access | Times Cited: 231
The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention
Seppe Cambier, Mieke Gouwy, Paul Proost
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 3, pp. 217-251
Open Access | Times Cited: 207
Seppe Cambier, Mieke Gouwy, Paul Proost
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 3, pp. 217-251
Open Access | Times Cited: 207
High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer
Stefan Salcher, Gregor Sturm, Lena Horvath, et al.
Cancer Cell (2022) Vol. 40, Iss. 12, pp. 1503-1520.e8
Open Access | Times Cited: 204
Stefan Salcher, Gregor Sturm, Lena Horvath, et al.
Cancer Cell (2022) Vol. 40, Iss. 12, pp. 1503-1520.e8
Open Access | Times Cited: 204
Neutrophil phenotypes and functions in cancer: A consensus statement
Daniela F. Quail, Borko Amulic, Monowar Aziz, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 195
Daniela F. Quail, Borko Amulic, Monowar Aziz, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 195
Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma
Areeg Elmusrati, Justin Wang, Cun‐Yu Wang
International Journal of Oral Science (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 176
Areeg Elmusrati, Justin Wang, Cun‐Yu Wang
International Journal of Oral Science (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 176
Type I interferon-mediated tumor immunity and its role in immunotherapy
Renren Yu, Bo Zhu, Degao Chen
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 173
Renren Yu, Bo Zhu, Degao Chen
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 173
Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
Diego Chowell, Seong‐Keun Yoo, Cristina Valero, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 4, pp. 499-506
Open Access | Times Cited: 168
Diego Chowell, Seong‐Keun Yoo, Cristina Valero, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 4, pp. 499-506
Open Access | Times Cited: 168
IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy
Álvaro Teijeira, Saray Garasa, María C. Ochoa, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 9, pp. 2383-2393
Open Access | Times Cited: 167
Álvaro Teijeira, Saray Garasa, María C. Ochoa, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 9, pp. 2383-2393
Open Access | Times Cited: 167
Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment
Shan Gao, Xiaoye Yang, Jiangkang Xu, et al.
ACS Nano (2021) Vol. 15, Iss. 8, pp. 12567-12603
Closed Access | Times Cited: 166
Shan Gao, Xiaoye Yang, Jiangkang Xu, et al.
ACS Nano (2021) Vol. 15, Iss. 8, pp. 12567-12603
Closed Access | Times Cited: 166
Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy
Jiahui Zhang, Cheng Ji, Hongbo Zhang, et al.
Science Advances (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 161
Jiahui Zhang, Cheng Ji, Hongbo Zhang, et al.
Science Advances (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 161
Tumor-associated myeloid cells: diversity and therapeutic targeting
Alberto Mantovani, Federica Marchesi, Sébastien Jaillon, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 566-578
Open Access | Times Cited: 143
Alberto Mantovani, Federica Marchesi, Sébastien Jaillon, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 566-578
Open Access | Times Cited: 143
Neutrophils as potential therapeutic targets in hepatocellular carcinoma
Daniel Geh, Jack Leslie, Rob Rumney, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 4, pp. 257-273
Closed Access | Times Cited: 141
Daniel Geh, Jack Leslie, Rob Rumney, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 4, pp. 257-273
Closed Access | Times Cited: 141
Tumor-associated neutrophils and neutrophil-targeted cancer therapies
Haiying Que, Qianmei Fu, Tianxia Lan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188762-188762
Open Access | Times Cited: 140
Haiying Que, Qianmei Fu, Tianxia Lan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188762-188762
Open Access | Times Cited: 140
Myeloid cell-targeted therapies for solid tumours
Sangeeta Goswami, Swetha Anandhan, Deblina Raychaudhuri, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 106-120
Closed Access | Times Cited: 136
Sangeeta Goswami, Swetha Anandhan, Deblina Raychaudhuri, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 106-120
Closed Access | Times Cited: 136